Dr. Ann Marie Egloff was born in Owosso, Michigan, in a family that deeply valued education and community involvement. Her mother, a science teacher, and her father, a school administrator, played significant roles in shaping her strong academic foundation and dedication to serving others. She excelled in math and science at Swartz Creek High School, earning honors. In addition to her academic achievements, she was involved in several extracurricular activities, including varsity basketball, track and field, diving, student council, theater, and ballet, showcasing her diverse interests and leadership qualities. After high school, Dr. Egloff pursued a Bachelor of Science in Cellular and Molecular Biology at the University of Michigan. This academic background set the stage for her career in biomedical research, beginning with a position at Warner-Lambert Parke-Davis. There, she worked on molecular cloning and the evaluation of small-molecule inhibitors for cancer and metabolic diseases, which earned her recognition for her contributions to the field. Her growing interest in scientific research led Dr. Egloff to pursue a PhD in Biochemistry, Cell, and Molecular Biology at Johns Hopkins School of Medicine. Her research focused on immune cell signaling pathways, critical for understanding the body's response to diseases. After completing her PhD, she went on to a postdoctoral fellowship at the National Human Genome Research Institute, where she studied cancer-causing gene mutations. This work earned her recognition and contributed significantly to the expanding field of cancer research. Dr. Egloff continued to build her career at the University of Pittsburgh, where she participated in an NIH/NCI-sponsored Cancer Education and Career Development Program. Her work aimed to bridge laboratory research with clinical applications, focusing on personalized cancer treatments. As an Assistant Professor at the University of Pittsburgh School of Medicine, she led groundbreaking research on head and neck cancers, contributing to the development of targeted therapies. In 2015, Dr. Egloff moved to Boston University, where she further expanded her research and mentorship roles. She now works at Brigham and Women's Hospital and Harvard Medical School, continuing her research on tumor immunology and precision cancer treatments. Dr. Ann Marie Egloff's work and career exemplify her commitment to advancing scientific research and mentoring the next generation of scientists. Her contributions to cancer research continue to have a lasting impact, and she remains dedicated to her field and community.